ASRT Lead Plaintiff Deadline Approaching: Assertio Holdings, Inc. Shareholders Should Contact Robbins LLP for Information About the Class Action Against ASRT
February 22, 2024 12:53 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Assertio Holdings, Inc.
AMPL Shareholder Alert: Contact Robbins LLP for Information About Your Rights and Remedies Against Amplitude, Inc. (AMPL)
February 20, 2024 15:25 ET
|
Robbins LLP
Robbins LLP Filed a Class Action Against Amplitude, Inc. on Behalf of Shareholders
NYCB Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against New York Community Bancorp, Inc.
February 20, 2024 15:20 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against New York Community Bancorp, Inc.
LUXH Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against LuxUrban Hotels Inc.
February 20, 2024 14:59 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against LuxUrban Hotels Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against InMode Ltd. (INMD)
February 15, 2024 19:45 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against InMode Ltd.
IRTC Class Action Alert: Robbins LLP Reminds Stockholders of Lead Plaintiff Deadline in iRhythm Technologies, Inc. Class Action
February 14, 2024 19:59 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against iRhythm Technologies, Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Xponential Fitness, Inc. (XPOF)
February 12, 2024 15:08 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Xponential Fitness, Inc.
EVVTY Shareholders are Reminded to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Evolution AB (publ) Class Action
February 12, 2024 13:41 ET
|
Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
BIVI Shareholders Who Lost Money Should Contact Robbins LLP for Information about the BioVie Inc. Class Action
February 10, 2024 00:51 ET
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
ALVR Shareholders Who Lost Money Should Contact Robbins LLP for Information About the AlloVir, Inc. Class Action
February 10, 2024 00:49 ET
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies